ESTROGEN REGULATION OF AORTIC MUSCLE COLLAGEN EXPRESSION
Project Number5R01HL035003-03
Contact PI/Project LeaderSONENSHEIN, GAIL E
Awardee OrganizationBOSTON UNIVERSITY MEDICAL CAMPUS
Description
Abstract Text
Pre-menopausal women appear to have a natural protection from heart attack
which is lost after menopause. One current hypothesis is that this
protection is attributable to the sex steroids, in particular to estrogens,
possibly working with other factors on vascular cells. Vascular smooth
muscle cells are responsible for production of the bulk of the connective
tissue protein in major arteries. Smooth muscle cell invasion into the
lumen of an artery and resulting connective tissue proliferation has been
implicated in the pathogenesis of atherosclerosis. Previous studies have
shown that these smooth muscle cells in culture are similarly capable of
synthesizing collagen, predominantly types I and III and lesser amounts of
basement membrane collagen, as well as elastin and glycosaminoglycans.
Administration of estrogens to animals lowers the production of collagen by
vascular smooth muscle cells. Recently, we observed that treatment of
these cells in culture with estradiol causes a similar reduction in the
quantity of procollagen produced. To further elucidate the mechanisms of
the estradiol effect, we plan to monitor three components of collagen
produced in rabbit vascular cell cultures: the intracellular soluble
procollagens, the extracellular souluble collagens in the medium and the
extracellular insoluble collagen incorporated into the matrix.
Distributions of the various collagen types in each of these compartments
will be assessed.
Experiments will be performed to distinguish between transcriptional,
pre-translational and post-translational levels of control. Collagen mRNA
will be monitored by employing a cell-free translation system as well as by
hybridization to cDNA clones specific for the individual collagen chains.
These values will be compared to the rate of transcription of the various
mRNA species, and we will seek to correlate these with alterations inthe
chromatin structure of collagen type I and type III genes. Since, in
preliminary studies, estradiol was found to alter the overall architecture
of the chromatin in smooth muscle cells, general structural and functional
evaluation of the chromatin will also be performed.
No Sub Projects information available for 5R01HL035003-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01HL035003-03
Patents
No Patents information available for 5R01HL035003-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01HL035003-03
Clinical Studies
No Clinical Studies information available for 5R01HL035003-03
News and More
Related News Releases
No news release information available for 5R01HL035003-03
History
No Historical information available for 5R01HL035003-03
Similar Projects
No Similar Projects information available for 5R01HL035003-03